Analysis of Abatacept Treatment Retention and Efficacy According to Disease Duration and Treatment Line in a Real-World Setting

被引：0
|
作者：
Alten, Rieke [1 ]
Mariette, Xavier [2 ]
Flipo, Rene-Marc [3 ]
Caporali, Roberto [4 ]
Buch, Maya [5 ]
Patel, Yusuf [6 ]
Sanmarti, Raimon [7 ]
Marsal, Sara [8 ]
Nurmohamed, Michael [9 ]
Ths, Hedley Griffi [10 ]
Peichl, Peter [11 ]
Bannert, Bettina [12 ]
Forster, Adrian [13 ]
Chartier, Melanie [14 ]
Elbez, Yedid [15 ]
Rauch, Christiane [16 ]
Khaychuk, Vadim [17 ]
Lozenski, Karissa [17 ]
机构：
[1] Schlosspk Klin Univ, Berlin, Germany
[2] Univ Paris Saclay, Hosp Bicetre, AP HP, Paris, France
[3] CHU France, Lille, France
[4] Policlin S Matteo Univ, Pavia, Italy
[5] Univ Leeds, Leeds, W Yorkshire, England
[6] Hull Royal Infirm, Kingston Upon Hull, N Humberside, England
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Hosp Univ Vall dHebron, Barcelona, Spain
[9] VU Univ Med & Reade, ARC Amsterdam Univ Hosp, Amsterdam, Netherlands
[10] Barwon Rheumatol Serv, Geelong, Vic, Australia
[11] Evangel Hosp, Vienna, Austria
[12] Univ Spital Basel, Basel, Switzerland
[13] Schulthess Klin, Zurich, Switzerland
[14] Bristol Myers Squibb, Rueil Malmaison, France
[15] Deepscover, Puteaux La Defense, France
[16] Bristol Myers Squibb, Munich, Germany
[17] Bristol Myers Squibb, Princeton, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
SUBCUTANEOUS ABATACEPT; RHEUMATOID-ARTHRITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0816
引用
收藏
页码：1680 / 1683
页数：4
相关论文
共 50 条
  • [1] ANALYSIS OF ABATACEPT TREATMENT RETENTION AND EFFICACY ACCORDING TO DISEASE DURATION AND TREATMENT LINE IN A REAL-WORLD SETTING
    Alten, R.
    Mariette, X.
    Flipo, R. M.
    Caporali, R.
    Buch, M. H.
    Patel, Y.
    Sanmarti, R.
    Marsal, S.
    Nurmohamed, M. T.
    Griffiths, H.
    Peichl, P.
    Bannert, B.
    Forster, A.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Khaychuk, V.
    Lozenski, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1128 - 1130
  • [2] Predicting RA Remission with Subcutaneous Abatacept Treatment in the Real-world Setting
    Alten, Rieke
    Rauch, Christiane
    Bannert, Bettina
    Marsal, Sara
    Buch, Maya
    Caporali, Roberto
    Chartier, Melanie
    Connolly, Sean
    Griffiths, Hedley
    Mariette, Xavier
    Nurmohamed, Michael
    Patel, Yusuf
    Peichl, Peter
    Sanmarti, Raimon
    Elbez, Yedid
    Lozenski, Karissa
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2533 - 2536
  • [3] Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting
    Ellis, Martin H.
    Lavi, Noa
    Mishchenko, Elena
    Dally, Najib
    Lavie, David
    Courevitch, Anna
    Gutwein, Odit
    Bulvik, Shlomo
    Braester, Andrei
    Chubar, Evgeni
    Tavor, Sigal
    Duek, Adrian
    Kirgner, Ilya
    Koren-Michowitz, Maya
    BLOOD, 2014, 124 (21)
  • [4] Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real-world setting in Taiwan
    Chen, Kun-Hung
    Li, Ko-Jen
    Fang, Yao-Fan
    Hsieh, Song-Chou
    Chen, Ying-Chou
    Lee, Chyou-Shen
    Luo, Shue-Fen
    Cheng, Tien-Tsai
    Tsai, Wen Chan
    Lo, Yu-Chen
    Lan, Joung-Liang
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (07)
  • [5] Efficacy of nivolumab/ipilimumab as first-line treatment of pleural mesothelioma in the German real-world setting
    Shah, Rajiv
    Reck, Martin
    Grohe, Christian
    Christoph, Daniel Christian
    Buchmeier, Eva Lotte
    Saalfeld, Felix Carl
    Frost, Nikolaj
    Kopp, Hans-Georg
    Faehling, Martin
    Griesinger, Frank
    Roeper, Julia
    Hoffknecht, Petra
    Kuon, Jonas
    Luan, Jingting
    Chesi, Paolo
    Christopoulos, Petros
    Thomas, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Real-world Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the ACTION Study
    Bensen, William
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Boumpas, Dimitrios
    Nurmohamed, Michael
    Burmester, Gerd
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Charner, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 985 - 985
  • [7] REAL-WORLD EFFICACY AND SAFETY OF ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: 12-MONTH INTERIM ANALYSIS OF THE ACTION STUDY
    Nusslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hannes M.
    Boumpas, Dimitrios
    Nurmohamed, Michael T.
    Bensen, William
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    RHEUMATOLOGY, 2013, 52 : 90 - 91
  • [8] CHANGE IN DISEASE ACTIVITY AND TREATMENT RESPONSE AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK
    Henning, S.
    Groves, L.
    Hurst, M.
    Sugrue, D.
    Gordon, J.
    Choy, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1442 - 1443
  • [9] The Challenge of Assessing Treatment Effectiveness in a Real-World Setting
    Smith, Alexandra
    CLINICAL THERAPEUTICS, 2021, 43 (11) : 2026 - 2029
  • [10] Adherence to anticoagulant treatment with dabigatran in a real-world setting
    Schulman, S.
    Shortt, B.
    Robinson, M.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 954 - 954
12345